Superbrewed Food has launched Thryt the development of digestive and immune health products across supplements, foods, beverages and pet nutrition
The US company said that the ingredient combined a growing scientific evidence base with formulation flexibility and commercial-scale supply
Thryyricum strain ASM19 and is shelf-stable at room temperature
According to Superbrewed Food, third-party preclinical research has demonstrated selective activation of the pattern-recognition receptors TLR2, TLR5 and NOD2, while animal studies have also provided translational evidence of intestinal and host-response activity
A completed four-week consumer perception study also reportedperceived improvements across multiple measures of digestive comfort, with further human studies ongoing
Formulation flexibility
As a non-lity to be maintained during manufacturing, distribution or storage
This allows it to be incorporated into a range of formats, including capsules, powders, gummies, bars, foods and beverages
The ingredient is also compatible with shelf-stable and UHT-processed applications, potentially broadening opportunities for formulators beyond traditional probiotic formats
Superbrewed Food said a typical inclusion level is approximately200 mg per serving
Thry to GRAS Notice GRN 1129
The launch is being supported by microbiome industry veteran MichaelBush, who has joined Superbrewed Food as co-Chair of the Board
Bush previously served as President and CEO of Ganeden, where he was involved in the development and commercialisation of branded probiotic ingredients
“As someone who has spent years in the microbiome space, I know exactly what it takes to bring a category-defining ingredient to market — and Thry
I’m thrilled to work alongside this team to bring fermented ingredients to market that meet real, unmet needs across the food, beverage, supplement and animal health industries
Superbrewed Food said it will offer formulation guidance, samples and claims-substantiation support to brands evaluating Thry
